Imagine a world where doctors could give their patients a list of every clinical trial they are eligible to join.

The trial met both primary endpoints, with tirzepatide showing a 38% decrease in heart failure outcomes compared to placebo.

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

BioStem Technologies has experienced significant price volatility driven by positive news and uplisting plans. Click here to ...

This roundup offers a look at the latest insights from the clinicians and researchers investigating chronic obstructive pulmonary disease and asthma.

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

In its third-quarter 2024 earnings report, Talphera highlighted the progress ... This quarter, the company also provided updates on the expansion of clinical sites and financial figures. The NEPHRO ...

The University of Texas Health Science Center at San Antonio (UT Health San Antonio) ranks at the top 5% of universities in the world for clinical medicine, and in the top 12% of universities overall ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with ...

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value ...